WO2001097820A3 - Kefir as a potent anti-oxidant composition - Google Patents

Kefir as a potent anti-oxidant composition Download PDF

Info

Publication number
WO2001097820A3
WO2001097820A3 PCT/CA2001/000899 CA0100899W WO0197820A3 WO 2001097820 A3 WO2001097820 A3 WO 2001097820A3 CA 0100899 W CA0100899 W CA 0100899W WO 0197820 A3 WO0197820 A3 WO 0197820A3
Authority
WO
WIPO (PCT)
Prior art keywords
kefir
subject
plasma
manufacturing process
oxidant
Prior art date
Application number
PCT/CA2001/000899
Other languages
French (fr)
Other versions
WO2001097820A2 (en
Inventor
Stan Kubow
Maryam Fotouhinia
Original Assignee
Univ Mcgill
Stan Kubow
Maryam Fotouhinia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcgill, Stan Kubow, Maryam Fotouhinia filed Critical Univ Mcgill
Priority to EP01949131A priority Critical patent/EP1408998A2/en
Priority to US10/311,770 priority patent/US20040028696A1/en
Priority to CA002417687A priority patent/CA2417687A1/en
Priority to AU2001270376A priority patent/AU2001270376A1/en
Publication of WO2001097820A2 publication Critical patent/WO2001097820A2/en
Publication of WO2001097820A3 publication Critical patent/WO2001097820A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to an anti-oxidant composition having reducing effect on plasma lipid peroxidation and plasma TNF-α; concentrations in a subject, which comprises an effective anti-oxidant amount of an end-product of kefir manufacturing process for oral administration to the subject. The present invention also relates to a method of reducing plasma indices of lipid peroxidation and plasma tumor necrosis factor-α concentrations in a subject, which comprises administering orally an effective anti-oxidant amount of end-product of kefir manufacturing process to the subject. The present invention also relates to a prophylactic composition having neutraceutical properties, which comprises a neutraceutical effective amount of an end-product of kefir manufacturing process for oral administration to a subject.
PCT/CA2001/000899 2000-06-22 2001-06-18 Kefir as a potent anti-oxidant composition WO2001097820A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP01949131A EP1408998A2 (en) 2000-06-22 2001-06-18 Kefir as a potent anti-oxidant composition
US10/311,770 US20040028696A1 (en) 2000-06-22 2001-06-18 Kefir as a potent anti-oxidant composition
CA002417687A CA2417687A1 (en) 2000-06-22 2001-06-18 Kefir as a potent anti-oxidant composition
AU2001270376A AU2001270376A1 (en) 2000-06-22 2001-06-18 Kefir as a potent anti-oxidant composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21326800P 2000-06-22 2000-06-22
US60/213,268 2000-06-22

Publications (2)

Publication Number Publication Date
WO2001097820A2 WO2001097820A2 (en) 2001-12-27
WO2001097820A3 true WO2001097820A3 (en) 2002-08-01

Family

ID=22794407

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2001/000899 WO2001097820A2 (en) 2000-06-22 2001-06-18 Kefir as a potent anti-oxidant composition

Country Status (5)

Country Link
US (1) US20040028696A1 (en)
EP (1) EP1408998A2 (en)
AU (1) AU2001270376A1 (en)
CA (1) CA2417687A1 (en)
WO (1) WO2001097820A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033282A1 (en) * 2000-06-16 2004-02-19 Stan Kubow Kefir extract as anti-cancer agent
JP2005348698A (en) * 2004-06-14 2005-12-22 Yonezawa Biru System Service:Kk Bacterium separated from kefir granule, bacterial culture obtained by culturing the bacterium or bacterium group containing the same and product obtained by using them
WO2007087722A1 (en) * 2006-02-02 2007-08-09 Kclm Research In Nutrition Inc. Use of soy kefir powder for reducing pain, blood pressure and inflammation
US20090196867A1 (en) * 2007-11-26 2009-08-06 Kclm Research In Nutrition Inc. Soy kefir powder and uses thereof
JP5222747B2 (en) * 2009-01-26 2013-06-26 日本ケフィア株式会社 Antioxidants using kefir

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797290A (en) * 1985-10-08 1989-01-10 Sennosuke Tokumaru Lyophilized process for the production of a kefir yoghurt

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4229440A (en) * 1978-11-27 1980-10-21 Fujiya Confectionery Company Limited Pharmaceutical composition containing the polysaccharide KGF-C as active ingredient
JP2811316B2 (en) * 1989-02-20 1998-10-15 協同乳業株式会社 Lactic acid bacteria beverage and method for producing the same
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
AU2001273614A1 (en) * 2000-06-21 2002-01-02 James Zhou LIU Health promoting foods

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797290A (en) * 1985-10-08 1989-01-10 Sennosuke Tokumaru Lyophilized process for the production of a kefir yoghurt

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
M. ZOMMARA ET AL.: "PREVENTION OF PEROXIDATIVE STRESS IN RATS FED ON A LOW VITAMIN E-CONTAINING DIET SUPPLEMENTED WITH A FERMENTED BOVINE MILK WHEY PREPARATION: EFECT OF LACTIC ACID AND BETA-LACTOGLOBULIN ON THE ANTIPEROXIDATIVE ACTION.", BIOSCIENCE, BIOTECHNOLOGY AND BIOCHEMISTRY, vol. 62, no. 4, April 1998 (1998-04-01), pages 710 - 717, XP001076819 *
M. ZOMMARA ET AL.: "WHEY FROM CULTURED SKIM MILK DECREASES SERUM CHOLESTEROL AND INCREASES ANTIOXIDANT ENZYMES IN LIVER AND RED BLOOD CELLS IN RATS.", NUTRITION RESEARCH, vol. 16, no. 2, 1996, pages 293 - 302, XP002198498 *
See also references of EP1408998A2 *

Also Published As

Publication number Publication date
AU2001270376A1 (en) 2002-01-02
US20040028696A1 (en) 2004-02-12
WO2001097820A2 (en) 2001-12-27
EP1408998A2 (en) 2004-04-21
CA2417687A1 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
AU2002216097A1 (en) Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
WO2003053336A3 (en) Methods for the treatment of peripheral neural and vascular ailments
CA2249501A1 (en) Method of preparing and using isoflavones
AU3946899A (en) Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug
WO2002009637A3 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
EP2298285A3 (en) Method of making particles for use in a pharmaceutical composition
AU2001286578A1 (en) Topical antioxidant having vitamin c and method of combination with topical agent by user
AU2002213977A1 (en) Novel anticholinergics, method for the production thereof and use thereof as medicaments
GB0406384D0 (en) Composition for reducing appetite in mammals comprising proxyanidin
WO2002036106A3 (en) Novel medicament compositions based on anticholinergics and corticosteroids
WO2002013766A3 (en) Valproic acid derivatives for the treatment of pain
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
WO2001070212A3 (en) Method and composition for preventing or reducing the symptoms of menopause
WO2003018376A3 (en) Brake rotor assembly and method for making same
WO2004071374A3 (en) Once a day orally administered pharmaceutical compositions
WO2001097820A3 (en) Kefir as a potent anti-oxidant composition
AU4671101A (en) Formulation for the prevention of cardiovascular disease
WO2003005967A3 (en) Dual release levodopa ethyl ester and decarboxylase in controlled release core
WO2002009679A3 (en) Use of 13-cis retinoic acid for the treatment of emphysema
BR9913231A (en) Manufacturing process of glucosyltransferase inhibitors from cocoa bean husks
WO2002100404A3 (en) Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes
CA2400300A1 (en) Method for producing shredded tobacco and production system for use therein
AU4651700A (en) Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
WO2001085139A3 (en) Semi-solid delivery vehicle and pharmaceutical compositions
WO2001074394A8 (en) New combination of a betablocker and a cholesterol-lowering agent

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2417687

Country of ref document: CA

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2001949131

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10311770

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001949131

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001949131

Country of ref document: EP